From Tarzan to Tolkien: Controlling the Language Proficiency Level of LLMs for Content Generation
Ali Malik, Stephen Mayhew, Chris Piech, Klinton Bicknell
TL;DR
The paper tackles the practical problem of controlling the language proficiency level of LLM-generated content for language learners by formalizing the Proficiency Control Task (PCT) and evaluating multiple strategies. It combines prompt-based methods, finetuning of open-source models, and reinforcement learning with PPO, along with a simple yet powerful top-$k$ sampling boost. A key contribution is CaLM (CEFR-Aligned Language Model), which, via finetuning plus PPO, matches GPT-4 performance at a fraction of the cost, and even dominates prompting-based GPT-4 in Pareto terms when combined with top-$k$ sampling. The work provides a synthetic TinyTolkien dataset and a broader methodological framework, with human evaluations confirming high quality and alignment to target proficiency, making the approach practical for education-focused content generation and tool-building. Overall, it demonstrates that open-source models can achieve GPT-4-level proficiency control at substantially lower compute, enabling scalable, CEFR-aligned content generation for learners.
Abstract
We study the problem of controlling the difficulty level of text generated by Large Language Models (LLMs) for contexts where end-users are not fully proficient, such as language learners. Using a novel framework, we evaluate the effectiveness of several key approaches for this task, including few-shot prompting, supervised finetuning, and reinforcement learning (RL), utilising both GPT-4 and open source alternatives like LLama2-7B and Mistral-7B. Our findings reveal a large performance gap between GPT-4 and the open source models when using prompt-based strategies. However, we show how to bridge this gap with a careful combination of finetuning and RL alignment. Our best model, CALM (CEFR-Aligned Language Model), surpasses the performance of GPT-4 and other strategies, at only a fraction of the cost. We further validate the quality of our results through a small-scale human study.
